In that case, Smg mechanism of action appeared to be different, since overexpression of Smg decreased DM1 muscle defects by reducing unproductive CUGBP1-eIF2α translational complexes [50]. The gene discussed is SAMD4A; the disease is myotonic dystrophy type 1.